Skip to content

Dokter Laurens Zelderloo

Active
Private limited companyfounded 20205 yrs activeRodestraat 42, 1570 Pajottegem, BelgiumKBO/BCE: BE 0755.674.936
Summary

The computed 12-month bankruptcy probability of Dokter Laurens Zelderloo is 2.1% (moderate). The 2025 annual accounts show equity of €228k and a net result of €223k. Equity is growing by ~44.1% per year across the filed fiscal years. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
57 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability87▲+3
Solvency40▼-29
Growth32▼-20
Track record94
Bankruptcy probability, 12 months
2.1% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity short (current ratio 0.73 against 6.44 in 2024; short-term debt: 16.7% and cash: 1.7% of total assets), and 84.9% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 5 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
15.1%
Return on assets
14.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
21 d early
2024
169 d early
2023
176 d early
2022
34 d early
2021
34 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€228k▼ 76.0%
2024 · €948k
2021: €264k 2022: €422k 2023: €693k 2024: €948k
2021 → 2025
Total assets
€1.51M▼ 29.3%
2024 · €2.14M
2021: €434k 2022: €645k 2023: €1.30M 2024: €2.14M
2021 → 2025
Net result
€223k▼ 12.6%
2024 · €255k
2021: €259k 2022: €158k 2023: €271k 2024: €255k
2021 → 2025
Working capital
€-68k
2024 · €709k
2021: €249k 2022: €390k 2023: €619k 2024: €709k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€264k-€422k▲ 59.8%€693k▲ 64.1%€948k▲ 36.7%€228k▼ 76.0%
Operating result€344k-€274k▼ 20.3%€292k▲ 6.5%€351k▲ 20.3%€327k▼ 6.7%
Net result€259k-€158k▼ 39.1%€271k▲ 71.4%€255k▼ 6.0%€223k▼ 12.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300k€400kOperating result 2021: €344k€344kNet result 2021: €259k€259kOperating result 2022: €274k€274kNet result 2022: €158k€158kOperating result 2023: €292k€292kNet result 2023: €271k€271kOperating result 2024: €351k€351kNet result 2024: €255k€255kOperating result 2025: €327k€327kNet result 2025: €223k€223k20212022202320242025€0€100k€200k€300k€400kOperating result 2023: €292k€292kNet result 2023: €271k€271kOperating result 2024: €351k€351kNet result 2024: €255k€255kOperating result 2025: €327k€327kNet result 2025: €223k€223k202320242025
The operating result falls in 2025; 2025 is 7% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.51M
Fixed assets €1.33M ▲ 2.2%
Current assets €184k ▼ 78.1%
Equity and liabilities €1.51M
Equity €228k ▼ 76.0%
Debt €1.29M ▲ 7.8%
Debt's share of the balance-sheet total rises from 55.7% to 84.9%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€406k
2024 · €391k
Cash flow
€301k
2024 · €295k
Current ratio
0.73
2024 · 6.44
Debt to equity
5.64
2024 · 1.26
ROE
97.8%
2024 · 26.9%
ROA
14.7%
2024 · 11.9%
Interest coverage
11.10
2024 · 14.16
Debt ≤ 1 year
€252k
2024 · €130k
Debt > 1 year
€1.03M
2024 · €1.06M
Income taxes
€70k
2024 · €73k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet Code20242025
Assets
Total assets20/58€2.14M€1.51M
Fixed assets21/28€1.30M€1.33M
Tangible fixed assets22/27€1.30M€1.33M
Land and buildings22€1.15M€1.16M
Plant, machinery and equipment23€7k€7k
Furniture and vehicles24€142k€165k
Current assets29/58€839k€184k
Amounts receivable within one year40/41€293k€6k
Trade receivables40-€1k
Other amounts receivable41€293k€5k
Current investments50/53€530k€146k
Cash at bank and in hand54/58€5k€25k
Deferred charges and accrued income490/1€11k€6k
Equity and liabilities
Total equity and liabilities10/49€2.14M€1.51M
Equity10/15€948k€228k
Contributions10/11€5k€5k=
Reserves13€943k€223k
Distributable reserves133€943k€223k
Profit (loss) carried forward14-€0
Amounts payable17/49€1.19M€1.29M
Amounts payable after more than one year17€1.06M€1.03M
Financial debts170/4€1.06M€1.03M
Amounts payable within one year42/48€130k€252k
Current portion of amounts payable after more than one year42€72k€74k
Financial debts43€660€2k
Credit institutions430/8€660€2k
Trade debts44€58k€28k
Suppliers440/4€58k€28k
Taxes, remuneration and social security45-€36k
Taxes450/3-€36k
Other amounts payable47/48€0€112k
Income statement Code20242025
Non-recurring operating income76A€73€0
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40k€79k
Other operating charges640/8€479€1k
Non-recurring operating charges66A€88€0
Gross operating margin9900€392k€408k
Operating profit (loss)9901€351k€327k
Financial income75/76B€4k€2k
Recurring financial income75€4k€2k
Financial charges65/66B€28k€37k
Recurring financial charges65€28k€37k
Profit (loss) for the period before taxes9903€327k€293k
Income taxes67/77€73k€70k
Profit (loss) for the period9904€255k€223k
Profit (loss) for the period to be appropriated9905€255k€223k
Appropriation of the result
Profit (loss) to be appropriated9906€255k€223k
Transfer from equity791/2-€943k
Transfer to equity691/2€255k€223k
To other reserves6921€255k€223k
Profit to be distributed694/7-€943k
Return on contributions (dividend)694-€943k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
10-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
12-02
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
06-02
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2021net €271k ▲71.4%
Net result €271k, the highest in the series.
31-12
Financial Equity above €500kEq €693k ▲64.1%
3 profitable years in a row build equity to €693k.
27-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Weakest financial yearnet €158k ▼39.1%
Net result drops to €158k, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity quadruplescurrent ratio 13.73
Current ratio from 3.08 to 13.73; short-term debt falls from €119k to €31k.
27-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Pajottegem · 1 establishment unit since 2020
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rodestraat 421570 Pajottegem
Ground area
1,410 m²
Building footprint
187 m²
Parcel 23023D0372/00H000, Flanders. Linked by address, not a title deed.
1 establishment unit
Dokter Laurens Zelderloo
Rodestraat 42, 1570 PajottegemGeneral medical practice
since 20202.310.219.306
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23023D0372/00H000 Flanders 1,410 m² 1 · 187 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

894500WC17KA4K6I5V52
live in the LEI register

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded05-10-2020
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.